Bartenstein P - Search Results

1

Additive value of [¹⁸F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome.

Katzdobler S, Nitschmann A, Barthel H, Bischof G, Beyer L, Marek K, Song M, Wagemann O, Palleis C, Weidinger E, Nack A, Fietzek U, Kurz C, Häckert J, Stapf T, Ferschmann C, Scheifele M, Eckenweber F, Biechele G, Franzmeier N, Dewenter A, Schönecker S, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Stephens AW, van Eimeren T, Neumaier B, Drzezga A, Danek A, Classen J, Bürger K, Janowitz D, Rauchmann BS, Stöcklein S, Perneczky R, Schöberl F, Zwergal A, Höglinger GU, Bartenstein P, Villemagne V, Seibyl J, Sabri O, Levin J, Brendel M; German Imaging Initiative for Tauopathies (GII4T). Katzdobler S, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):423-434. doi: 10.1007/s00259-022-05964-w. Epub 2022 Sep 14. Eur J Nucl Med Mol Imaging. 2023. PMID: 36102964 Free PMC article.

2

18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis.

Drzezga A, Arnold S, Minoshima S, Noachtar S, Szecsi J, Winkler P, Römer W, Tatsch K, Weber W, Bartenstein P. Drzezga A, et al. Among authors: bartenstein p. J Nucl Med. 1999 May;40(5):737-46. J Nucl Med. 1999. PMID: 10319744 Free article.

3

[18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors.

Gründer G, Siessmeier T, Lange-Asschenfeldt C, Vernaleken I, Buchholz HG, Stoeter P, Drzezga A, Lüddens H, Rösch F, Bartenstein P. Gründer G, et al. Among authors: bartenstein p. Eur J Nucl Med. 2001 Oct;28(10):1463-70. doi: 10.1007/s002590100594. Eur J Nucl Med. 2001. PMID: 11685488

4

Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.

Teipel SJ, Willoch F, Ishii K, Bürger K, Drzezga A, Engel R, Bartenstein P, Möller HJ, Schwaiger M, Hampel H. Teipel SJ, et al. Among authors: bartenstein p. Neurobiol Aging. 2006 May;27(5):681-90. doi: 10.1016/j.neurobiolaging.2005.03.015. Neurobiol Aging. 2006. PMID: 15908048

5

Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease.

Bokde AL, Teipel SJ, Drzezga A, Thissen J, Bartenstein P, Dong W, Leinsinger G, Born C, Schwaiger M, Moeller HJ, Hampel H. Bokde AL, et al. Among authors: bartenstein p. Dement Geriatr Cogn Disord. 2005;20(6):352-7. doi: 10.1159/000088558. Epub 2005 Sep 26. Dement Geriatr Cogn Disord. 2005. PMID: 16192725

6

Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial.

Teipel SJ, Drzezga A, Bartenstein P, Möller HJ, Schwaiger M, Hampel H. Teipel SJ, et al. Among authors: bartenstein p. Psychopharmacology (Berl). 2006 Jul;187(1):86-94. doi: 10.1007/s00213-006-0408-1. Epub 2006 Jun 1. Psychopharmacology (Berl). 2006. PMID: 16767418 Clinical Trial.

7

The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes.

la Fougère C, Pöpperl G, Levin J, Wängler B, Böning G, Uebleis C, Cumming P, Bartenstein P, Bötzel K, Tatsch K. la Fougère C, et al. Among authors: bartenstein p. J Nucl Med. 2010 Apr;51(4):581-7. doi: 10.2967/jnumed.109.071811. Epub 2010 Mar 17. J Nucl Med. 2010. PMID: 20237026 Free article.

8

Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study.

Saam T, Rominger A, Wolpers S, Nikolaou K, Rist C, Greif M, Cumming P, Becker A, Foerster S, Reiser MF, Bartenstein P, Hacker M. Saam T, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1203-12. doi: 10.1007/s00259-010-1432-2. Epub 2010 Mar 19. Eur J Nucl Med Mol Imaging. 2010. PMID: 20300933

9

Detection of low-grade prosthetic joint infections using 99mTc-antigranulocyte SPECT/CT: initial clinical results.

Graute V, Feist M, Lehner S, Haug A, Müller PE, Bartenstein P, Hacker M. Graute V, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1751-9. doi: 10.1007/s00259-010-1431-3. Epub 2010 Mar 23. Eur J Nucl Med Mol Imaging. 2010. PMID: 20309680

10

PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT.

Pfluger T, Melzer HI, Schneider V, La Fougere C, Coppenrath E, Berking C, Bartenstein P, Weiss M. Pfluger T, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2011 May;38(5):822-31. doi: 10.1007/s00259-010-1702-z. Epub 2011 Jan 6. Eur J Nucl Med Mol Imaging. 2011. PMID: 21210112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

702 results

Search Page